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Absence of Association Between Asthma and High Serum
Immunoglobulin E Associated GPRA Haplotypes and Adult
Atopic Dermatitis
To the Editor:
Atopic dermatitis (AD) is a chronic relapsing inflammatory
skin disease that affects 10%–15% of children and 2%–
10% of adults (Williams, 1997). The skin in AD is typically
dry and excoriated due in part to reduced ability of the
epidermis to hold water. Immunological mechanisms are
thought to play a critical pathogenic role with AD being as-
sociated with high immunoglobulin E (IgE) levels and the
accumulation of T lymphocytes of the Th2 subtype in in-
volved skin (Galli et al, 2003). AD is also associated with
atopic diseases in other organs such as asthma and allergic
rhinitis (Mortz et al, 2001). Atopy reflects a genetic predis-
position for excessive IgE antibody production with 80% of
children with AD generating serum concentrations of IgE
typically five fold increased (Stone, 1973; Johansson et al,
2001). Whilst the pathogenesis of AD is unclear, family and
twin studies support a significant genetic component
underlying predisposition to the phenotype (Kuster et al,
1990). Furthermore, genome-wide scans for susceptibility
loci have reported a number of chromosomal loci linked to
the disease (Lee et al, 2000; Cookson et al, 2001; Bradley
et al, 2002).
Association studies provide a powerful method for iso-
lating disease loci and a recent study of asthma patients
and high serum IgE responders from isolated cohorts in
Finland identified risk haplotypes from a 133 kb region on
chromosome 7p (Laitinen et al, 2004). Located within this
interval, a G protein-coupled receptor gene, GPRA, showed
altered distribution patterns between bronchial biopsies
from healthy and asthmatic individuals (Laitinen et al, 2004).
This association has been further supported by two recent
reports of asthma patients. These included a large German
study (Kormann et al, 2005) and a cohort drawn from five
Western European countries (Mele´n et al, 2005). Evidence of
association was not observed in a Korean cohort (Shin et al,
2004), in which only a single-nucleotide polymorphism
(SNP) was examined and as such may not have fully dis-
tinguished between the risk and non-risk haplotypes across
the GPRA locus. The GPRA gene is also expressed in skin
keratinocytes raising the possibility that variation in
this gene may directly contribute to predisposition to AD
(Laitinen et al, 2004).
To investigate inherited susceptibility to AD we examined
seven SNP that characterize or ‘‘tag’’ the seven haplotypes
spanning GPRA identified by Laitinen et al (2004). These
were genotyped in 188 adult patients of Northern European
descent and in 221 age- and sex-matched controls. Ethical
approval was given by the medical ethics committee of
St Thomas’s Hospital and informed written consent was
obtained from all participating subjects. The study was
conducted according to Declaration of Helsinki Principles.
All patients were diagnosed using standard clinical criteria
of Hanifin and Rajka by experienced dermatologists (Hani-
fin, 1992). Minimum age at study was 18 y indicating that
this cohort had persistence or recurrence into adulthood.
Further these patients in general had increased disease
activity compared with childhood AD. Taken together this
suggests that this patient group represents a more severe
phenotype. The positions of the SNP markers are listed in
Table I with respect to genomic contig NT_000380. Geno-
typing of samples was performed by size assessment
of primer extension products using the MALDI-TOF mass
spectrometry Sequenom system (Jurinke et al, 2002).
Genotype frequencies were found to be in Hardy–Weinb-
erg equilibrium. Allele frequencies for each SNP were com-
pared between patients and controls using w2 contingency
tables. Haplotypes of the seven SNP were constructed
separately for patients and controls using PHASE (Stephens
et al, 2000).
The allele frequencies for the seven markers in the pa-
tients and the controls are shown in Table I. No significant
differences were observed in the allele frequencies between
the patients and controls. Control allele frequencies were
similar to those of the study by Laitinen et al (2004) and also
to a German control population (Kormann et al, 2005). Ha-
plotypes inferred using PHASE were used to assess wheth-
er specific haplotypes may harbor AD susceptibility alleles.
These haplotypes were also compared with those observed
in the asthma and high IgE cohorts (Laitinen et al, 2004).
Similar haplotype frequencies were observed between the
controls in this study and the controls reported in the asth-
ma study and in those ascertained from Kormann et al
(2005). An additional haplotype with a frequency greater
than 2.5% was observed in this study by comparison with
those reported in the asthma study (Hn, Table II). These
haplotypes represented 96% of the haplotypes present in
the cohort studied and no single haplotype accounted for
more than 35% of the total. No overall statistical significant
differences in haplotype frequencies were observed be-
tween AD patients and controls (Table II). These data imply
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that variants in GPRA are unlikely to contribute to inherited
predisposition to AD.
High IgE levels are a characteristic of AD and GPRA is
associated with IgE levels. We, therefore, considered it pru-
dent to determine if any association between GPRA SNP
genotypes or haplotypes and IgE levels in the AD patients
exists. The IgE data did not fit a normal distribution hence
non-parametric rank-sum tests were used. No significant
relationship was seen for any SNP genotype and IgE using
the Kruskal–Wallis test or for any particular haplotype and
IgE using the Mann–Whitney test. A subtype of AD exists in
which the clinical criteria for AD are fulfilled in the absence
of high serum IgE levels. This subtype may be caused
through the activation of inflammation via different path-
ways not involving IgE. In this cohort only eight AD patients
had normal serum IgE levels (o100 kU per liter), a sample
set not large enough for statistical analysis. Hence at this
time we simply note a decrease in the frequency of non-risk
haplotypes (haplotypes h1, h3, and h6 in Table II; 56% in the
controls, 38% in the AD patients with normal IgE levels) and
a corresponding increase in risk haplotypes (haplotypes h2,
h4, h5, h7) described for asthma and high serum IgE by
Laitinen et al (2004).
In this report we have investigated the hypothesis that
genetic variation in the GPRA gene is associated with AD, a
disease in which high serum IgE levels are a characteristic
feature. We found no significant differences in either indi-
vidual allele frequencies or haplotype frequencies for seven
Table I. Allele frequencies in atopic dermatitis (AD) patients and controls for single-nucleotide polymorphism (SNP) from the
asthma susceptibility region GPRA
Markera
Allele frequencies
pv2
Patients Controls
Frequency Proportion Frequency Proportion
515224C 351 0.94 414 0.94 NS
515224G 21 0.06 26 0.06
522363C 155 0.41 172 0.39 NS
522363G 221 0.59 270 0.61
529556C 197 0.55 228 0.56 NS
529556A 163 0.45 176 0.44
546333G 331 0.94 393 0.93 NS
546333A 21 0.06 29 0.07
555608T 202 0.54 230 0.53 NS
555608C 174 0.46 204 0.47
563704T 127 0.34 159 0.37 NS
563704C 249 0.66 271 0.63
585883G 322 0.86 388 0.89 NS
585883C 52 0.14 48 0.11
aPosition of SNP relative to genomic contig NT_000380 (Laitinen et al, 2004).
Table II. Haplotypes with a frequency greater than 2.5% within atopic dermatitis (AD) patient and control cohorts
Haplotypea
Markers Haplotype frequencies
515224 522363 529556 546333 555608 563704 585883 Patients, n¼338 Controls, n¼ 364
H1 C G C G C T G 110 (33%) 121 (33%)
H2 C C A G T C G 65 (19%) 79 (22%)
H3 C G C G C C G 49 (14.5%) 42 (11.5%)
H4 C C A A T C C 20 (6.0%) 26 (7.0%)
H5 C C A G T C C 24 (7%) 13 (3.5%)
H6 C G C G T C G 31 (9%) 41 (11%)
H7 G C A G T C G 19 (5.5%) 19 (5.0%)
Hn C G A G T C G 12 (3.5%) 11 (3.0%)
aHaplotypes labelled according to Laitinen et al (2004), Hn indicates a haplotype not previously described.
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SNP surrounding GPRA between patients and controls. In a
small subset of AD patients with normal serum IgE levels
potential association with GPRA was observed. But inves-
tigation of this will require a larger collection of adult AD
patients with normal serum IgE levels. Although no signif-
icant association has been observed for the common form
of high serum IgE level AD, the study by Laitinen et al (2004)
provides evidence for the role of GPRA in atopy in general
and identification of genes in the GPRA signalling pathway
combined with data from genome-wide linkage studies
should serve to identify further candidates for AD.
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